REG vs TERN · P/E 34, $12.93B cap vs $6.12B cap
Regency Centers Corporation (REG) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
REG does not have a complete income-statement cache yet.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
REG currently screens at market cap $12.93B and trailing P/E 33.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the REG and TERN stock pages for the full models.
Not investment advice.